Selected research
Industry Research
Pregabalin Capsule Industry Research Report 2026
Market perspective
The global Pregabalin Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pregabalin Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pregabalin Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pregabalin Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pregabalin Capsule include Wan Vee Pharm, Succeway Pharmaceuticals, Qilu Pharmaceutical, Pfizer, Stat Rx USA, Angita Pharma, Actavis Pharma and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pregabalin Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pregabalin Capsule Market by Company
Wan Vee Pharm
Succeway Pharmaceuticals
Qilu Pharmaceutical
Pfizer
Stat Rx USA
Angita Pharma
Actavis Pharma
Accord Healthcare
Pregabalin Capsule Segment by Type
75mg Capsule
50mg Capsule
25mg Capsule
Others
Pregabalin Capsule Segment by Application
Clinics
Hospitals
Others
Pregabalin Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pregabalin Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pregabalin Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pregabalin Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pregabalin Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 75mg Capsule
- 50mg Capsule
- 25mg Capsule
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Wan Vee Pharm
- Succeway Pharmaceuticals
- Qilu Pharmaceutical
- Pfizer
- Stat Rx USA
- Angita Pharma
- Actavis Pharma
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pregabalin Capsule Market Size (2021-2032)
- 2.2.2 Global Pregabalin Capsule Sales (2021-2032)
- 2.2.3 Global Pregabalin Capsule Market Average Price (2021-2032)
- 2.3 Pregabalin Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 75mg Capsule
- 2.3.3 50mg Capsule
- 2.3.4 25mg Capsule
- 2.3.5 Others
- 2.4 Pregabalin Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pregabalin Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pregabalin Capsule Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pregabalin Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global Pregabalin Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global Pregabalin Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pregabalin Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pregabalin Capsule, Product Type & Application
- 3.8 Global Manufacturers of Pregabalin Capsule, Established Date
- 3.9 Global Pregabalin Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wan Vee Pharm
- 4.1.1 Wan Vee Pharm Company Information
- 4.1.2 Wan Vee Pharm Business Overview
- 4.1.3 Wan Vee Pharm Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wan Vee Pharm Pregabalin Capsule Product Portfolio
- 4.1.5 Wan Vee Pharm Recent Developments
- 4.2 Succeway Pharmaceuticals
- 4.2.1 Succeway Pharmaceuticals Company Information
- 4.2.2 Succeway Pharmaceuticals Business Overview
- 4.2.3 Succeway Pharmaceuticals Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio
- 4.2.5 Succeway Pharmaceuticals Recent Developments
- 4.3 Qilu Pharmaceutical
- 4.3.1 Qilu Pharmaceutical Company Information
- 4.3.2 Qilu Pharmaceutical Business Overview
- 4.3.3 Qilu Pharmaceutical Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Pharmaceutical Pregabalin Capsule Product Portfolio
- 4.3.5 Qilu Pharmaceutical Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Pregabalin Capsule Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Stat Rx USA
- 4.5.1 Stat Rx USA Company Information
- 4.5.2 Stat Rx USA Business Overview
- 4.5.3 Stat Rx USA Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Stat Rx USA Pregabalin Capsule Product Portfolio
- 4.5.5 Stat Rx USA Recent Developments
- 4.6 Angita Pharma
- 4.6.1 Angita Pharma Company Information
- 4.6.2 Angita Pharma Business Overview
- 4.6.3 Angita Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Angita Pharma Pregabalin Capsule Product Portfolio
- 4.6.5 Angita Pharma Recent Developments
- 4.7 Actavis Pharma
- 4.7.1 Actavis Pharma Company Information
- 4.7.2 Actavis Pharma Business Overview
- 4.7.3 Actavis Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Actavis Pharma Pregabalin Capsule Product Portfolio
- 4.7.5 Actavis Pharma Recent Developments
- 4.8 Accord Healthcare
- 4.8.1 Accord Healthcare Company Information
- 4.8.2 Accord Healthcare Business Overview
- 4.8.3 Accord Healthcare Pregabalin Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Accord Healthcare Pregabalin Capsule Product Portfolio
- 4.8.5 Accord Healthcare Recent Developments
5 Global Pregabalin Capsule Market Scenario by Region
- 5.1 Global Pregabalin Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pregabalin Capsule Sales by Region: 2021-2032
- 5.2.1 Global Pregabalin Capsule Sales by Region: 2021-2026
- 5.2.2 Global Pregabalin Capsule Sales by Region: 2027-2032
- 5.3 Global Pregabalin Capsule Revenue by Region: 2021-2032
- 5.3.1 Global Pregabalin Capsule Revenue by Region: 2021-2026
- 5.3.2 Global Pregabalin Capsule Revenue by Region: 2027-2032
- 5.4 North America Pregabalin Capsule Market Facts & Figures by Country
- 5.4.1 North America Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pregabalin Capsule Sales by Country (2021-2032)
- 5.4.3 North America Pregabalin Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pregabalin Capsule Market Facts & Figures by Country
- 5.5.1 Europe Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pregabalin Capsule Sales by Country (2021-2032)
- 5.5.3 Europe Pregabalin Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pregabalin Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pregabalin Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pregabalin Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pregabalin Capsule Market Facts & Figures by Country
- 5.7.1 South America Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pregabalin Capsule Sales by Country (2021-2032)
- 5.7.3 South America Pregabalin Capsule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pregabalin Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pregabalin Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pregabalin Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pregabalin Capsule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pregabalin Capsule Sales by Type (2021-2032)
- 6.1.1 Global Pregabalin Capsule Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pregabalin Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global Pregabalin Capsule Revenue by Type (2021-2032)
- 6.2.1 Global Pregabalin Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pregabalin Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global Pregabalin Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pregabalin Capsule Sales by Application (2021-2032)
- 7.1.1 Global Pregabalin Capsule Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pregabalin Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global Pregabalin Capsule Revenue by Application (2021-2032)
- 7.2.1 Global Pregabalin Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pregabalin Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global Pregabalin Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pregabalin Capsule Value Chain Analysis
- 8.1.1 Pregabalin Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pregabalin Capsule Production Mode & Process
- 8.2 Pregabalin Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pregabalin Capsule Distributors
- 8.2.3 Pregabalin Capsule Customers
9 Global Pregabalin Capsule Analyzing Market Dynamics
- 9.1 Pregabalin Capsule Industry Trends
- 9.2 Pregabalin Capsule Industry Drivers
- 9.3 Pregabalin Capsule Industry Opportunities and Challenges
- 9.4 Pregabalin Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst